NP Life Sciences Health Industry Group Inc. (ACAT) Revenue 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$164,621FY2023 · since FY2019: $43,000 → $164,621
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $164,621 | +61.4% |
| FY2022 | $102,002 | +191.5% |
| FY2021 | $34,992 | +133.3% |
| FY2020 | $15,000 | -65.1% |
| FY2019 | $43,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAT financial trends
ACAT Net incomeACAT Net marginACAT Gross profitACAT Gross marginACAT Operating incomeACAT Operating marginACAT Operating cash flowACAT Free cash flowACAT Capital expendituresACAT Return on equityACAT Stock buybacksACAT Dividends paidACAT Total assetsACAT Total liabilitiesACAT Shareholders’ equityACAT overview →